Takeda Group Begins Manufacturing Covid-19 Plasma Treatment Ahead of Approval

The group, known as the CoVIg Plasma Alliance, enrolled its first patient in the Phase III trial on Friday after months of delays. It aims to enroll 500 adult patients from the United States, Mexico and 16 other countries and hope to have results by the end of the year.

from Top World News- News18.com https://ift.tt/312G4CS